missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Volociximab Chimeric Recombinant Human Monoclonal Antibody (M200 (Volociximab))

Description
The antibody binds to human alpha 5 Beta 1 integrin with a Kd of 0.367 nM (determined by Biacore), an EC50 of 0.2 nM and an IC50 of 2.3 nM.
Volociximab is a biosimilar that targets ITGA5.
Specifications
Specifications
| Antigen | Volociximab Chimeric |
| Applications | ELISA, Flow Cytometry, Inhibition Assays, Immunohistochemistry, Immunocytochemistry |
| Classification | Recombinant Monoclonal |
| Clone | M200 (Volociximab) |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% ProClin 300 |
| Gene Alias | 558480-40-3; M20 |
| Host Species | Human |
| Immunogen | Heterodimeric Human alpha 5 Beta 1 Fc fusion protein. |
| Show More |